FAURN HARRISON: Open Payments
NPI 1609097302 · BOWIE, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$928 in 38 payments from 11 companies in 2025. Trend: 2023 $506 · 2024 $435 · 2025 $928
Food & beverage: $928
| Company | Payments | Amount |
|---|---|---|
| Boston Scientific Corporation | 8 | $278 |
| Collegium Pharmaceutical, Inc. | 6 | $137 |
| Saluda Medical Americas, Inc. | 3 | $115 |
| Abbott Laboratories | 4 | $79 |
| MML US, Inc. | 5 | $74 |
| VERTEX PHARMACEUTICALS INCORPORATED | 3 | $67 |
| BIOTRONIK NRO, Inc. | 3 | $54 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $43 |
| ABBVIE INC. | 2 | $39 |
| Medtronic, Inc. | 1 | $21 |
Products named: WaveWriter Alpha Prime 16, XTAMPZA, Evoke, ETERNA, ReActiv8, JOURNAVX, RELISTOR, Prospera.
Industry payments across MD — which companies pay providers there.
